MEDIFIC

develops the MEDIcine of the First-in-Class by drugging the undruggable targets.

develops innovative drugs targeting cancer stem cells to prevent recurrence and metastasis.

is committed to providing better treatment solutions to brain cancer patients.

VALUES

Translating and Innovating Deep Science into Drug Discovery and Development
for the Treatment of Cancer and Better Life of the Patients.

Development of first-in-class anticancer drugs for targeting cancer stem cell
Development of exosome-based cancer immunotherapy

CSCs have been recognized as a key target
for successful cancer treatment.

Exosomes are valuable therapeutic modality
because of their multiple advantages.

MEDIFIC has core competencies
to meet a variety of unmet medical needs.